The latest leukaemia news
New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of…
Browsing: Leukaemia
Researchers discover drug resistance mechanism in leukemia, ID treatment strategy
Like packaging designed to create a protective environment around a product, the mix of cells…
Benefits of Venetoclax endure years after blood cancer clinical trial
A study which tracked the long-term outcomes of blood cancer patients involved in the MURANO…
An area of the brain where tumour cells shelter from chemotherapy in childhood leukaemia
The stroma of the choroid plexus is one of the locations within the central nervous…
Potential cause of immunotherapy-related neurotoxicity
New research has uncovered the previously unknown presence of CD19 — a B cell molecule…
Novel immune-oncology approach for potential cancer treatment
A research collaboration between Monash University and Lava Therapeutics details a novel immune-oncology approach for…
Whole genome sequencing recommended to improve treatment targeting for leukaemia patients
Researchers have identified a new gene mutation causing treatment resistance in acute lymphoblastic leukaemia. The…
FDA approves azacitidine tablets for acute myeloid leukaemia
On September 1, 2020, the Food and Drug Administration approved azacitidine tablets (ONUREG) for continued…
First drug-like compounds to inhibit elusive cancer-linked enzymes developed
A team of scientists from the University of Michigan Rogel Cancer Center, USA, has developed…
CircASXL1-1 regulates BAP1 deubiquitinase activity in leukaemia
Every year, 1.1 million new cases of blood cancers are diagnosed worldwide. Presently, chemotherapy remains…